|

Injection of humanized nerve growth factor (NGF) antibody Clinical Trials

1 actively recruiting trial

Also known as: SSS40

Pipeline

Phase 1/2: 1

Top Sponsors

  • Shenyang Sunshine Pharmaceutical Co., LTD.1

Indications

  • Cancer Pain1
  • Cancer1

Other1 trial

Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.